Apelin/APJ Signalling as a Potential Complementary Target for Glucagon-like Peptide-1 Receptor Agonist Therapy in Heart Failure [0.03%]
Dominic Marcel Alfonso
Dominic Marcel Alfonso
María Noël Brögger,Ivonne Johana Cárdenas Reyes,Soledad García Hernández et al.
María Noël Brögger et al.
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease and is characterised by unexplained increased wall thickness. Traditionally considered a monogenic disorder, emerging evidence highlights its complex genetic arc...
Olives Nguyen,Daniel Kamna,Ahmad Masri
Olives Nguyen
End-stage hypertrophic cardiomyopathy (ES-HCM) presents on a spectrum between the classic left ventricular systolic dysfunction and a less-recognised, restrictive phenotype with small-to-normal-sized left ventricular cavity and preserved ej...
The Role of Glucagon-like Peptide-1 in the Pathophysiology of Heart Failure: A Special Focus [0.03%]
肠促胰素-1在心力衰竭病理生理中的作用：特别关注点
Amina Rakisheva,Anton Zatsarinnyy
Amina Rakisheva
Archana Ganapathy,Jason N Dungu,Anthony D Dimarco et al.
Archana Ganapathy et al.
Congestion is a typical clinical feature of acute decompensated heart failure (ADHF), causing symptoms and unplanned hospitalisation. Suboptimal decongestion during admission and residual congestion at hospital discharge contribute to adver...
Phrenic Nerve Stimulation for Central Sleep Apnoea: When and Why? [0.03%]
中枢性睡眠呼吸暂停的膈神经刺激：何时使用及为什么使用？
Jonathan Na,Miguel Valderrabano,Paul Schurmann
Jonathan Na
Central sleep apnoea (CSA) is a sleep-disordered breathing condition characterised by diminished or absent respiratory effort during sleep due to instability in the respiratory control system. While various treatments exist, ranging from po...
Reverse Remodelling, Myocardial Recovery and Remission in Heart Failure with Reduced Ejection Fraction: Clinical Implications and Management Strategies [0.03%]
射血分数降低的心力衰竭中逆转重构、心肌恢复与缓解的临床意义和管理策略
Silas Ramos Furquim,Maria Tereza Sampaio de Sousa Lira,Deborah de Sá Pereira Belfort et al.
Silas Ramos Furquim et al.
Cardiac reverse remodelling (RR) is a complex process involving structural and functional recovery of the myocardium, with significant implications for the prognosis of patients with heart failure (HF). This review summarises current concep...
Josip Andelo Borovac,Dino Miric
Josip Andelo Borovac
Ventricular-Arterial Coupling in Heart Failure with Preserved Ejection Fraction: A Bibliometric Review and Clinical Implications [0.03%]
射血分数保留的心力衰竭患者室壁耦合的文献计量学分析及临床意义
Tianzong Li,Yiran Luo,Lina Zhao et al.
Tianzong Li et al.
Heart failure remains a growing global health burden, and early disruptions in ventricular-arterial coupling (VAC) contribute to its pathogenesis, particularly in heart failure with preserved ejection fraction (HFpEF). We conducted an integ...
Positive Airway Pressure Therapies for Heart Failure: What Do the Trials Tell Us? [0.03%]
心衰患者的正压通气治疗：临床试验说了什么？
Jan Pec,Michael Arzt
Jan Pec
Sleep-disordered breathing (SDB) represents a modifiable treatment target in patients with heart failure (HF). Despite the evolution of positive airway pressure (PAP) therapy over the past several decades, randomised controlled trials have ...